Insider Selling: Phreesia, Inc. (NYSE:PHR) CFO Sells $132,261.24 in Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 4,813 shares of the business’s stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $27.48, for a total transaction of $132,261.24. Following the transaction, the chief financial officer now owns 144,933 shares in the company, valued at $3,982,758.84. This represents a 3.21 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Price Performance

PHR opened at $28.47 on Friday. The company’s 50-day simple moving average is $24.98 and its two-hundred day simple moving average is $23.28. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market capitalization of $1.65 billion, a P/E ratio of -19.37 and a beta of 0.94. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.90.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter in the prior year, the firm earned ($0.58) earnings per share. The firm’s revenue for the quarter was up 16.6% compared to the same quarter last year. As a group, analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Hedge Funds Weigh In On Phreesia

A number of institutional investors and hedge funds have recently modified their holdings of the company. Champlain Investment Partners LLC increased its position in Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after acquiring an additional 97,847 shares during the last quarter. Franklin Resources Inc. increased its position in shares of Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares during the last quarter. State Street Corp lifted its stake in shares of Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after buying an additional 55,934 shares during the last quarter. Finally, TimesSquare Capital Management LLC grew its position in Phreesia by 2.3% during the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock valued at $19,791,000 after buying an additional 19,395 shares during the period. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research report on Friday, January 10th. KeyCorp raised their target price on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, January 8th. Piper Sandler reissued an “overweight” rating and issued a $33.00 price target (up from $31.00) on shares of Phreesia in a research report on Wednesday. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Finally, Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and boosted their target price for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. Thirteen research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $31.15.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.